Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 16, 2021
Reporting Period: Fiscal fourth quarter and full year ended December 31, 2020.
This filing serves to announce the release of financial results for the fourth quarter and fiscal year 2020 via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only confirms that results for the fourth quarter and fiscal year 2020 have been announced.
Guidance, Outlook, and Management Commentary
According to the description of Exhibit 99.1, the company introduced fiscal year 2021 guidance in the associated press release. No specific guidance figures, risks, contingencies, or unusual items are detailed in the 8-K text itself.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific Q4 and full-year 2020 financial results.
- Verify the specific details of the fiscal year 2021 guidance mentioned in the press release.
- Confirm any material changes in financial condition or operations not explicitly detailed in this summary.